224 related articles for article (PubMed ID: 28025584)
1. Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.
da Silva Filho MI; Försti A; Weinhold N; Meziane I; Campo C; Huhn S; Nickel J; Hoffmann P; Nöthen MM; Jöckel KH; Landi S; Mitchell JS; Johnson D; Morgan GJ; Houlston R; Goldschmidt H; Jauch A; Milani P; Merlini G; Rowcieno D; Hawkins P; Hegenbart U; Palladini G; Wechalekar A; Schönland SO; Hemminki K
Leukemia; 2017 Aug; 31(8):1735-1742. PubMed ID: 28025584
[TBL] [Abstract][Full Text] [Related]
2. Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.
Gu M; Wilton R; Stevens FJ
Contrib Nephrol; 2007; 153():156-81. PubMed ID: 17075229
[TBL] [Abstract][Full Text] [Related]
3. Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
Berghaus N; Schreiner S; Poos AM; Raab MS; Goldschmidt H; Mai EK; Salwender HJ; Bernhard H; Thurner L; Müller-Tidow C; Weinhold N; Hegenbart U; Schönland SO; Huhn S
FEBS J; 2023 Sep; 290(17):4256-4267. PubMed ID: 37097223
[TBL] [Abstract][Full Text] [Related]
4. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
[TBL] [Abstract][Full Text] [Related]
5. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.
Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS
Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.
Weinhold N; Försti A; da Silva Filho MI; Nickel J; Campo C; Hoffmann P; Nöthen MM; Hose D; Goldschmidt H; Jauch A; Langer C; Hegenbart U; Schönland SO; Hemminki K
Leukemia; 2014 Nov; 28(11):2254-6. PubMed ID: 24990613
[No Abstract] [Full Text] [Related]
7. Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis.
Abraham RS; Ballman KV; Dispenzieri A; Grill DE; Manske MK; Price-Troska TL; Paz NG; Gertz MA; Fonseca R
Blood; 2005 Jan; 105(2):794-803. PubMed ID: 15388584
[TBL] [Abstract][Full Text] [Related]
8. Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance.
Chattopadhyay S; Thomsen H; Weinhold N; Meziane I; Huhn S; da Silva Filho MI; Vodicka P; Vodickova L; Hoffmann P; Nöthen MM; Jöckel KH; Schmidt B; Landi S; Hajek R; Hallmans G; Pettersson-Kymmer U; Ohlsson C; Milani P; Merlini G; Rowcieno D; Hawkins P; Hegenbart U; Palladini G; Wechalekar A; Schönland SO; Houlston R; Goldschmidt H; Hemminki K; Försti A
Leukemia; 2020 Apr; 34(4):1187-1191. PubMed ID: 31695157
[No Abstract] [Full Text] [Related]
9. Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
Elad S; Czerninski R; Fischman S; Keshet N; Drucker S; Davidovich T; Goldschmidt N
Amyloid; 2010 Mar; 17(1):27-31. PubMed ID: 20146645
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
[TBL] [Abstract][Full Text] [Related]
11. An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.
Nevone A; Girelli M; Mangiacavalli S; Paiva B; Milani P; Cascino P; Piscitelli M; Speranzini V; Cartia CS; Benvenuti P; Goicoechea I; Fazio F; Basset M; Foli A; Nanci M; Mazzini G; Caminito S; Sesta MA; Casarini S; Rognoni P; Lavatelli F; Petrucci MT; Olimpieri PP; Ricagno S; Arcaini L; Merlini G; Palladini G; Nuvolone M
Leukemia; 2022 Aug; 36(8):2076-2085. PubMed ID: 35610346
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes of Cyclin D1-Positive AL Amyloidosis.
Tsushima T; Terao T; Narita K; Fukumoto A; Ikeda D; Kamura Y; Kuzume A; Tabata R; Miura D; Takeuchi M; Matsue K
Am J Clin Pathol; 2023 Aug; 160(2):157-163. PubMed ID: 36940250
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
Wang S; Huang Y; Su R; Fang Z; Han M
Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
[TBL] [Abstract][Full Text] [Related]
14. Differences in immunoglobulin light chain species found in urinary exosomes in light chain amyloidosis (Al).
Ramirez-Alvarado M; Ward CJ; Huang BQ; Gong X; Hogan MC; Madden BJ; Charlesworth MC; Leung N
PLoS One; 2012; 7(6):e38061. PubMed ID: 22723846
[TBL] [Abstract][Full Text] [Related]
15. Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis.
Zhou P; Hoffman J; Landau H; Hassoun H; Iyer L; Comenzo RL
Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):49-58. PubMed ID: 22100494
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.
Meziane I; Huhn S; Filho MIDS; Weinhold N; Campo C; Nickel J; Hoffmann P; Nöthen MM; Jöckel KH; Landi S; Mitchell JS; Johnson D; Jauch A; Morgan GJ; Houlston R; Goldschmidt H; Milani P; Merlini G; Rowcieno D; Hawkins P; Hegenbart U; Palladini G; Wechalekar A; Försti A; Schönland SO; Hemminki K
Haematologica; 2017 Oct; 102(10):e411-e414. PubMed ID: 28679651
[No Abstract] [Full Text] [Related]
17. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
[TBL] [Abstract][Full Text] [Related]
18. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
Kimura K; Tsukamoto S; Miyazaki K; Kawajiri-Manako C; Ishii A; Rahmutulla B; Fukuyo M; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Matsusaka K; Sanada M; Yokote K; Kaneda A; Ishida T; Suzuki K; Nakaseko C; Sakaida E
Exp Hematol; 2021 Sep; 101-102():34-41.e4. PubMed ID: 34411686
[TBL] [Abstract][Full Text] [Related]
19. Identification of miRSNPs associated with the risk of multiple myeloma.
Macauda A; Calvetti D; Maccari G; Hemminki K; Försti A; Goldschmidt H; Weinhold N; Houlston R; Andersen V; Vogel U; Buda G; Varkonyi J; Sureda A; Martinez Lopez J; Watek M; Butrym A; Sarasquete ME; Dudziński M; Jurczyszyn A; Druzd-Sitek A; Kruszewski M; Subocz E; Petrini M; Iskierka-Jażdżewska E; Raźny M; Szombath G; Marques H; Zawirska D; Chraniuk D; Halka J; Hove Jacobsen SE; Mazur G; García Sanz R; Dumontet C; Moreno V; Stępień A; Beider K; Pelosini M; Manuel Reis R; Krawczyk-Kulis M; Rymko M; Avet-Loiseau H; Lesueur F; Grząśko N; Ostrovsky O; Jamroziak K; Vangsted AJ; Jerez A; Tomczak W; Zaucha JM; Kadar K; Sainz J; Nagler A; Landi S; Gemignani F; Canzian F
Int J Cancer; 2017 Feb; 140(3):526-534. PubMed ID: 27718532
[TBL] [Abstract][Full Text] [Related]
20. Search for AL amyloidosis risk factors using Mendelian randomization.
Saunders CN; Chattopadhyay S; Huhn S; Weinhold N; Hoffmann P; Nöthen MM; Jöckel KH; Schmidt B; Landi S; Goldschmidt H; Milani P; Merlini G; Rowcieno D; Hawkins P; Hegenbart U; Palladini G; Wechalekar A; Schönland SO; Försti A; Houlston R; Hemminki K
Blood Adv; 2021 Jul; 5(13):2725-2731. PubMed ID: 34228109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
